Related Experiment Video
Updated: Jul 9, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between the cardiometabolic index and chronic kidney disease: a cross-sectional study
Qian Guo1, Yani Wang1, Yuchen Liu1
1Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China.
Insights
Higher cardiometabolic index (CMI), an indicator of central obesity, is linked to increased chronic kidney disease (CKD) risk in the general American population. This study found a significant association between elevated CMI levels and a greater likelihood of developing CKD.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Central obesity is a known risk factor for chronic kidney disease (CKD).
- The specific relationship between the cardiometabolic index (CMI) and CKD prevalence requires further investigation.
- Understanding this association is crucial for public health strategies targeting metabolic syndrome and kidney health.
Purpose of the Study:
- To investigate the correlation between the cardiometabolic index (CMI) and the risk of chronic kidney disease (CKD).
- To assess the association in a large, representative sample of the general American population.
- To determine if higher CMI levels are independently associated with increased CKD risk.
Main Methods:
- A cross-sectional study utilizing data from 64,313 participants aged 20 years and older from the National Health and Nutrition Examination Survey (NHANES) (1999-2020).
- Participants were categorized into three groups based on CMI tertiles (T1, T2, T3).
- Logistic regression analysis, incorporating NHANES-recommended weights, was employed to evaluate the association between CMI and CKD.
Main Results:
- The overall prevalence of CKD among the 21,765 included participants was 12.2%.
- CKD prevalence increased significantly with rising CMI tertiles, from 8.9% in T1 to 16.0% in T3 (P < 0.001).
- After adjusting for confounders, higher CMI tertiles demonstrated a significantly higher risk of CKD (T3 vs. T1: OR 1.22, 95% CI 1.05-1.43, P=0.013).
Conclusions:
- Elevated cardiometabolic index (CMI) is independently associated with an increased risk of chronic kidney disease (CKD).
- These findings highlight the importance of monitoring CMI as a potential indicator for CKD risk in the general population.
- Public health initiatives may benefit from incorporating CMI assessment in strategies for preventing and managing kidney disease.
Background:
Central obesity is a risk factor for chronic kidney disease (CKD). However, the exact correlation between the cardiometabolic index (CMI), an indicator of central obesity, and CKD remains unclear. Here, we aimed to investigate the correlation between the CMI and CKD in the general American population.
Methods:
This cross-sectional study involved 64,313 members of the general population (≥ 20 years of age) with data in the National Health and Nutrition Examination Survey (NHANES) 1999-2020. The individuals were grouped into three categories by CMI tertile: T1 group (n = 7,029), T2 group (n = 7,356), and T3 group (n = 7,380). Logistic regression analysis was performed, with NHANES recommended weights, to assess the association between the CMI and CKD.
Results:
A total of 21,765 participants were included; the overall prevalence of CKD was 12.2%. From the low to the high CMI tertile, the prevalence of CKD increased from 8.9% to 16.0% (P < 0.001). After full adjustment for confounders, the higher tertile of CMI (OR: 1.08, 95% CI: 1.03 - 1.13, P = 0.002) had the higher risk of CKD. Compared with the T1 group, the groups with higher CMI levels had a higher CKD risk (T2: OR: 1.01, 95%CI: 0.87-1.18, P = 0.812; T3: OR: 1.22, 95%CI: 1.05-1.43, P = 0.013).
Conclusions:
Higher CMI was independently associated with higher CKD risk in the general population.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Nephrons
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...

